Product Information
RISPERIDONE ER 37.5 MG VIAL is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $556.6988 per EA under NDC 70748027113. Its NADAC has been published 33 times since Jan 7, 2026.
FDA first approved this application on Sep 2, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the risperidone market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Manufacturer
Lupin Pharmaceuticals Inc.NDC
70748027113
Classification
Generic
Dosage Form
KIT
Effective Date
8/19/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA211220FDA Approved
9/2/2025
TE Code
AB
On Market Since
10/17/2025
Price Statistics
The NADAC for RISPERIDONE ER 37.5 MG VIAL has been published 33 times since Jan 7, 2026, and over the history we have for it it has declined 23.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $556.6988 per EA |
|---|---|
| All-time high | $729.8571 (Jun 10, 2026) |
| All-time low | $554.8895 (Jul 22, 2026) |
| 52-week high | $729.8571 |
| 52-week low | $554.8895 |
| Median price | $729.8571 |
| Average price | $678.5618 |
| Largest weekly change | -22.5% (Jun 17, 2026) |
| Weeks tracked | 33 |
| Tracking since | Jan 7, 2026 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 43% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of RISPERIDONE ER 37.5 MG VIAL?
The current National Average Drug Acquisition Cost (NADAC) for RISPERIDONE ER 37.5 MG VIAL, manufactured by Lupin Pharmaceuticals Inc., is $556.6988 per EA (NDC 70748027113), effective Aug 19, 2026.
How has the price of RISPERIDONE ER 37.5 MG VIAL changed over time?
Over the history we have for it, the NADAC for RISPERIDONE ER 37.5 MG VIAL has declined 23.7%. It has been tracked across 33 weekly CMS publications since Jan 7, 2026.
What are the highest and lowest recorded NADAC prices for RISPERIDONE ER 37.5 MG VIAL?
Since Jan 7, 2026, the NADAC for RISPERIDONE ER 37.5 MG VIAL has ranged from a low of $554.8895 (Jul 22, 2026) to a high of $729.8571 (Jun 10, 2026), with a median of $729.8571 per EA.
Are there cheaper alternatives to RISPERIDONE ER 37.5 MG VIAL?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, RISPERDAL CONSTA 12.5 MG VIAL, is $317.9314 per EA — about 43% below RISPERIDONE ER 37.5 MG VIAL.
Who manufactures RISPERIDONE ER 37.5 MG VIAL?
RISPERIDONE ER 37.5 MG VIAL (NDC 70748027113) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.